Tip:
Highlight text to annotate it
X
We were part of the original group of investigators looking at a new treatment for breast cancer
called Herceptin. And we were dealing with some patients who were extremely ill who got
better right before our eyes. And that was one of the most rewarding experiences of my
life in medicine. That medication was approved about 10 years ago, and now it's part of the
standard of care for breast cancer. And Rush was right in on the ground floor. It's pretty
neat to be taking a chance on a new treatment strategy not involving chemotherapy, surgery
or radiation. We like the idea of using the patient's own immune system to help fight
her cancer, and we watch tumors basically melt away over a period of a week or two.